Tag: orsiro
CRT 2022: Final BIOFLOW-V results “affirm durability” of Orsiro out to five years
Final five-year resul...
CRT 2021: Biodegradable polymer sirolimus-eluting stent shows ‘promising’ results in STEMI patients
Thomas Pilgrim (Bern, S...
CRT 2020: Biotronik reports three-year results for Orsiro DES from BIOFLOW-V trial
Biotronik has announc...
ESC 2019: Ultrathin strut Orsiro better than thin strut Xience for STEMI patients
One-year data from th...
Orsiro may be the new benchmark for comparison in drug-eluting stent trials
At the 2018 Transcath...
TCT 2018: Orsiro continues to have lower rates of target lesion failure than Xience
Two-year data from th...
ESC 2018: Higher all-cause mortality with Orsiro at five years than with Xience
According to the five...
TCT 2016: All comers study finds no differences between Orsiro, Synergy and Resolute Integrity
BIO-RESORT, presented at ...
Risk of device thrombosis may be significantly higher with Absorb than with Xience, Promus or Orsiro
A network meta-analys...
